In Honor of Alzheimer's Disease Awareness Month

Learn about this prescription medicine for patients with moderate Alzheimer’s disease [Caring logo] From Caring.com: Below is a special message on behalf of our partners, which we hope you'll find valuable. [Prescribing Information]( [Important Risk Information]( Dear Caregiver, In honor of Alzheimer’s Disease Awareness Month we wanted to bring to light available treatments for moderate to severe Alzheimer’s disease (AD). Ask your loved one’s healthcare provider about all available treatment options that may be beneficial. [Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement][Advertisement] [purple ribbon]( Did you know? [chronometer] EVERY 66 SECONDS someone in the United States develops Alzheimer’s disease1 According to a U.S.-based survey, nearly 50% OF AD PATIENTS are already in the MODERATE TO SEVERE STAGE AT THE TIME OF DIAGNOSIS2 [Learn More About the Symptoms of Moderate Alzheimer’s Disease]( [arrow]( NAMZARIC® (memantine HCl and donepezil HCl) extended-release capsules is the FIRST AND ONLY once-a-day capsule that works on two pathways in the brain to fight the symptoms of moderate to severe AD. NAMZARIC may: • Improve cognition, also known as mental function • Improve overall function • Slow down the worsening of symptoms for a while There is no evidence that NAMZARIC prevents or slows the underlying disease process in patients with AD. Keep in mind, it takes time for any treatment to begin working. If your loved one is being treated for moderate to severe Alzheimer’s disease, symptoms may progress more slowly, remain the same for a period of time, or show some improvements for a period of time. [Getting Started]( [arrow]( [NAMZARIC Trial Offer]( INDICATION AND USAGE NAMZARIC (memantine HCl and donepezil HCl) extended-release capsules is a prescription medicine approved to treat moderate to severe Alzheimer’s disease in patients who are taking donepezil hydrochloride 10 mg, the active ingredient in Aricept®. IMPORTANT RISK INFORMATION NAMZARIC should not be taken by anyone who: has an allergy to memantine HCl, donepezil HCl, medicines that contain piperidines, or any of the ingredients in NAMZARIC. Please see additional [Important Risk Information below](#information). IMPORTANT RISK INFORMATION (continued) Before taking NAMZARIC, tell the doctor about all of the patient’s medical conditions, including: • heart problems including an irregular, slow, or fast heartbeat • asthma or lung problems • seizures • stomach ulcers • bladder, kidney, or liver problems • any surgical, dental, or other medical procedures scheduled when anesthesia may be used Tell the doctor about all the medicines the patient takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. What are the possible side effects of NAMZARIC? NAMZARIC may cause serious side effects, including: • muscle problems in patients given anesthesia • slow heartbeat and fainting. This happens more often in people with heart problems. Call the doctor right away if the patient faints while taking NAMZARIC. • more stomach acid. This raises the chance of ulcers and bleeding especially when taking NAMZARIC. The risk is higher for patients who have had ulcers, or take aspirin or other NSAIDs. • nausea and vomiting • difficulty passing urine • seizures • worsening of lung problems in people with asthma or other lung disease The most common side effects of memantine HCl include: headache, diarrhea, and dizziness. The most common side effects of donepezil HCl include: diarrhea, not wanting to eat (anorexia), and bruising. These are not all the possible side effects of NAMZARIC. Please see full [Prescribing Information]( including Patient Information. References: 1. Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement. 2016;12(4):459-509. 2. Alzheimer’s Disease Physician Study ©2013 GfK Healthcare. For more information about NAMZARIC, please visit [Namzaric.com]( or call Allergan Medical Information toll-free at 1.800.678.1605. PLEASE NOTE: DO NOT REPLY TO THIS EMAIL. Emails sent to this account will not be read. We respect your privacy. See our [Privacy Statement](. Allergan® and its design are trademarks of Allergan, Inc. NAMZARIC® and its design are trademarks of Merz Pharma GmbH & Co. KGaA. All other trademarks and product names are the property of their respective owners. © 2017 Allergan. All rights reserved. NMZ111467 10/17 [Allergan logo]( This message was intended for {EMAIL}. You received this e-mail because our records indicate that you're willing to receive offers from Caring.com and our partners. If you no longer wish to receive such offers, please [unsubscribe](. All content © 2007-2017 Caring, Inc., 2600 S. El Camino Real, Suite 300, San Mateo, CA 94403. All rights reserved. - - - - - - - - - - - - - - - - - - - - - - - -